ROTEM in Patients With Placenta Previa
Launched by SEOUL NATIONAL UNIVERSITY BUNDANG HOSPITAL · Dec 26, 2019
Trial Information
Current as of August 11, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Cesarean section under spinal anesthesia
- • Placenta previa
- • Placenta accreta
- • Placenta increta
- • Placenta percreta
- Exclusion Criteria:
- • Coagulopathy
- • Medication with antiplatelets or anticoagulants
About Seoul National University Bundang Hospital
Seoul National University Bundang Hospital is a leading academic medical center located in South Korea, renowned for its commitment to innovative research and excellence in patient care. As a sponsor of clinical trials, the hospital leverages its extensive expertise in various medical fields, employing cutting-edge technologies and methodologies to advance healthcare solutions. With a multidisciplinary team of skilled researchers and clinicians, the hospital aims to enhance clinical outcomes through rigorous investigation and collaboration, contributing significantly to the global medical community and improving patient lives.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seongnam, , Korea, Republic Of
Seongnam, Kyǒnggi Do, Korea, Republic Of
Seongnam, Gyeonggi, Korea, Republic Of
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials